Targeting MAPK14 by Lobeline Upregulates Slurp1‐Mediated Inhibition of Alternative Activation of TAM and Retards Colorectal Cancer Growth DOI Creative Commons
Mingxia Zhao, Lisha Zhou, Qinchang Zhang

et al.

Advanced Science, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 22, 2025

Abstract Colorectal cancer (CRC) usually creates an immunosuppressive microenvironment, thereby hindering immunotherapy response. Effective treatment options remain elusive. Using scRNA‐seq analysis in a tumor‐bearing murine model, it is found that lobeline, alkaloid from the herbal medicine lobelia, promotes polarization of tumor‐associated macrophages (TAMs) toward M1‐like TAMs while inhibiting their M2‐like TAMs. Additionally, lobeline upregulates mRNA expression secreted Ly‐6/UPAR‐related protein 1 ( Slurp1 ) cells. The inhibitory effects on tumor load and TAM are almost completely eliminated when Slurp1‐deficient MC38 cells subcutaneously injected into mice, suggesting exerts antitumor effect Slurp1‐dependent manner. Furthermore, using target‐responsive accessibility profiling, MAPK14 identified as direct target lobeline. Mechanistically, upon binding to colon cells, prevents nuclear translocation MAPK14, resulting decreased levels phosphorylated p53. Consequently, negative transcriptional regulation SLURP1 by p53 suppressed, leading enhanced transcription secretion SLURP1. Finally, combination therapy anti‐PD1 exhibits stronger effects. Taken together, these findings suggest remodeling microenvironment small‐molecule may represent promising therapeutic strategy for CRC.

Language: Английский

Lactate metabolism in human health and disease DOI Creative Commons
Xiaolu Li, Yanyan Yang, Bei Zhang

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2022, Volume and Issue: 7(1)

Published: Sept. 1, 2022

Abstract The current understanding of lactate extends from its origins as a byproduct glycolysis to role in tumor metabolism, identified by studies on the Warburg effect. shuttle hypothesis suggests that plays an important bridging signaling molecule coordinates among different cells, organs and tissues. Lactylation is posttranslational modification initially reported Professor Yingming Zhao’s research group 2019. Subsequent confirmed lactylation vital component function involved proliferation, neural excitation, inflammation other biological processes. An indispensable substance for various physiological cellular functions, regulatory aspects energy metabolism signal transduction. Therefore, comprehensive review summary presented clarify disease provide reference direction future research. This offers systematic overview homeostasis roles pathological processes, well effects diseases, particularly cancer.

Language: Английский

Citations

676

Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis DOI Creative Commons
Jie Cai, Lulu Sun, Frank J. Gonzalez

et al.

Cell Host & Microbe, Journal Year: 2022, Volume and Issue: 30(3), P. 289 - 300

Published: March 1, 2022

Language: Английский

Citations

464

TGF-β signaling in health and disease DOI Creative Commons
Joan Massagué, Dean Sheppard

Cell, Journal Year: 2023, Volume and Issue: 186(19), P. 4007 - 4037

Published: Sept. 1, 2023

The TGF-β regulatory system plays crucial roles in the preservation of organismal integrity. signaling controls metazoan embryo development, tissue homeostasis, and injury repair through coordinated effects on cell proliferation, phenotypic plasticity, migration, metabolic adaptation, immune surveillance multiple types shared ecosystems. Defects signaling, particularly epithelial cells, fibroblasts, disrupt tolerance, promote inflammation, underlie pathogenesis fibrosis cancer, contribute to resistance these diseases treatment. Here, we review how coordinates multicellular response programs health disease this knowledge can be leveraged develop treatments for system.

Language: Английский

Citations

349

Gut microbiota in colorectal cancer development and therapy DOI
Chi Chun Wong, Jun Yu

Nature Reviews Clinical Oncology, Journal Year: 2023, Volume and Issue: 20(7), P. 429 - 452

Published: May 11, 2023

Language: Английский

Citations

318

The interplay between diet and the gut microbiome: implications for health and disease DOI
Fiona C. Ross, Dhrati Patangia, Ghjuvan Micaelu Grimaud

et al.

Nature Reviews Microbiology, Journal Year: 2024, Volume and Issue: 22(11), P. 671 - 686

Published: July 15, 2024

Language: Английский

Citations

145

Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer DOI Creative Commons
Ruize Qu, Yi Zhang,

Yanpeng Ma

et al.

Advanced Science, Journal Year: 2023, Volume and Issue: 10(23)

Published: June 1, 2023

Colorectal cancer (CRC) is the most common of digestive system with high mortality and morbidity rates. Gut microbiota found in intestines, especially colorectum, has structured crosstalk interactions host that affect several physiological processes. The gut include CRC-promoting bacterial species, such as Fusobacterium nucleatum, Escherichia coli, Bacteroides fragilis, CRC-protecting Clostridium butyricum, Streptococcus thermophilus, Lacticaseibacillus paracasei, which along other microorganisms, viruses fungi, play critical roles development CRC. Different features are identified patients early-onset CRC, combined different patterns between fecal intratumoral microbiota. may be beneficial diagnosis treatment CRC; some bacteria serve biomarkers while others regulators chemotherapy immunotherapy. Furthermore, metabolites produced by essential CRC cells. Harmful primary bile acids short-chain fatty acids, whereas others, including ursodeoxycholic acid butyrate, impede tumor progression. This review focuses on its metabolites, their potential development, diagnosis,

Language: Английский

Citations

121

Oxidative Stress, Inflammation and Colorectal Cancer: An Overview DOI Creative Commons
Annamária Bardelčíková, Jindřich Šoltýs, Ján Mojžíš

et al.

Antioxidants, Journal Year: 2023, Volume and Issue: 12(4), P. 901 - 901

Published: April 9, 2023

Colorectal cancer (CRC) represents the second leading cause of cancer-related deaths worldwide. The pathogenesis CRC is a complex multistep process. Among other factors, inflammation and oxidative stress (OS) have been reported to be involved in initiation development CRC. Although OS plays vital part life all organisms, its long-term effects on human body may different chronic diseases, including diseases. Chronic can lead oxidation biomolecules (nucleic acids, lipids proteins) or activation inflammatory signaling pathways, resulting several transcription factors dysregulation gene protein expression followed by tumor cell survival. In addition, it well known that intestinal diseases such as bowel disease (IBD) are associated with an increased risk cancer, link between IBD progression has reported. This review focuses role causative agent colorectal cancer.

Language: Английский

Citations

117

Evaluation of the association of chronic inflammation and cancer: Insights and implications DOI Open Access
Manisha Nigam, Abhay Prakash Mishra,

Vishal Kumar Deb

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2023, Volume and Issue: 164, P. 115015 - 115015

Published: June 15, 2023

Among the most extensively researched processes in development and treatment of cancer is inflammatory condition. Although acute inflammation essential for wound healing reconstruction tissues that have been damaged, chronic may contribute to onset growth a number diseases, including cancer. By disrupting signaling cells, which result induction, invasion, development, variety molecules are linked The microenvironment surrounding tumor greatly influenced by cells their subsequent secretions, also significantly tumor's growth, survivability, potential migration. These variables mentioned several publications as prospective diagnostic tools anticipating Targeting with various therapies can reduce response potentially limit or block proliferation cells. scientific medical literature from past three decades has studied determine how chemicals cell pathways related invasion metastasis related. current narrative review updates relevant while highlighting specifics possible therapeutic possibilities.

Language: Английский

Citations

111

N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA DOI Creative Commons
Xiao Zheng, Qi Wang, You Zhou

et al.

Cancer Communications, Journal Year: 2022, Volume and Issue: 42(12), P. 1347 - 1366

Published: Oct. 8, 2022

Abstract Background N‐acetyltransferase 10 ( NAT10 ) is the only enzyme known to mediate N4‐acetylcytidine (ac4C) modification of mRNA and crucial for stability translation efficiency. However, its role in cancer development prognosis has not yet been explored. This study aimed examine possible colon cancer. Methods The expression levels were evaluated by immunohistochemical analyses with a tissue microarray, prognostic value patients was further analyzed. Quantitative real‐time polymerase chain reaction (qRT‐PCR) Western blotting performed analyze harvested tissues cell lines. Stable ‐knockdown ‐overexpressing lines constructed using lentivirus. biological functions analyzed vitro Cell Counting Kit‐8 (CCK‐8), wound healing, Transwell, cycle, ferroptosis assays. Xenograft models used effect on tumorigenesis metastasis cells vivo. Dot blotting, acetylated RNA immunoprecipitation‐qPCR, explore mechanism which progression. Results upregulated various increased associated shorter patient survival. Knockdown two (HT‐29 LoVo) impaired proliferation, migration, invasion, tumor formation these cells, whereas overexpression promoted abilities. Further analysis revealed that exerted strong suppressor protein 1 FSP1 HT‐29 LoVo cells. In found be modified ac4C acetylation, this epigenetic inhibition ferroptosis. Conclusions Our plays critical affecting ferroptosis, suggesting could novel therapeutic target

Language: Английский

Citations

103

Chemokines in colon cancer progression DOI
Shengnan Jia, Yingbo Han,

Rui Yang

et al.

Seminars in Cancer Biology, Journal Year: 2022, Volume and Issue: 86, P. 400 - 407

Published: Feb. 7, 2022

Language: Английский

Citations

100